Introduction & Objectives: Renal cell cancer (RCC) substantially lacks of biomarkers to assist clinicians in diagnosis, prognosis and response to therapy. Recent studies have demonstrated that the urinary proteome or peptidome is more complex than expected. The aim of this study is to compare the peptidomic profile of urine from RCC patients and healthy controls defined by Mass Spectrometr
Gardi, M., Fanali, C., Recupero, S., Iavarone, F., Destito, A., Vittori, M., Volpe, A., Sacco, E., Pinto, F., Inziatari, R., Dal Bianco, M., De Zorzi, L., Castagnola, M., Bassi, P., URINARY PROTEOMICS IN RENAL CELL CANCER BY MALDI-TOF MASS SPECTROMETRY:A PRELIMINARY CONTROLLED STUDY, <<EUROPEAN UROLOGY. SUPPLEMENTS>>, 2011; 10 (2): 233-233 [http://hdl.handle.net/10807/3176]
URINARY PROTEOMICS IN RENAL CELL CANCER BY MALDI-TOF MASS SPECTROMETRY:A PRELIMINARY CONTROLLED STUDY
Gardi, Mario;Fanali, Chiara;Iavarone, Federica;Destito, Antonio;Vittori, Matteo;Sacco, Enrico;Pinto, Francesco;Castagnola, Massimo;
2011
Abstract
Introduction & Objectives: Renal cell cancer (RCC) substantially lacks of biomarkers to assist clinicians in diagnosis, prognosis and response to therapy. Recent studies have demonstrated that the urinary proteome or peptidome is more complex than expected. The aim of this study is to compare the peptidomic profile of urine from RCC patients and healthy controls defined by Mass Spectrometr
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
